# Mechanisms of Dupilumab in AERD

> **NCT05031455** · PHASE2 · COMPLETED · sponsor: **Scripps Clinic** · enrollment: 16 (actual)

## Conditions studied

- Aspirin-exacerbated Respiratory Disease

## Interventions

- **DRUG:** Aspirin Challenge

## Key facts

- **NCT ID:** NCT05031455
- **Lead sponsor:** Scripps Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-25
- **Primary completion:** 2026-04-20
- **Final completion:** 2026-04-20
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2026-04-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05031455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05031455, "Mechanisms of Dupilumab in AERD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05031455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*